A Few Steps Ahead to Select ACE۲ in Pediatric COVID-۱۹ Treatment: A Review of Literature

This review study aimed to examine the relationship between Coronavirus (COVID-۱۹) and its uses in renin-angiotensin-aldosterone system (RAAS) to infect the patient using the related studies in this regard. Finally, the logical method of using the related medicine, and the benefits and harms of using these Medications will be indicated in the treatment of novel coronavirus. It is hoped that a short step will be taken in the attitude of scientists to plan further studies on the pediatric treatment of upgrading COVID-۱۹.

Keywords:

ACE۲ enzyme , COVID-۱۹ , Pediatrics

Authors

Seyed Hhosein Soleimanzadeh Mousavi

Resident of Pediatric, Department of Pediatrics, School of Medicine, Ali-Ibn-Abitaleb Hospital, Zahedan University of Medical Sciences, Zahedan, Iran.

Zeinab Tavakolikia

Medical Practitioner, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.

Certificate
من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

https://civilica.com/doc/1738708

شناسه ملی سند علمی:

JR_INJPM-8-9_020

تاریخ نمایه سازی: 5 شهریور 1402

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:

Soleimanzadeh Mousavi, Seyed Hhosein and Tavakolikia, Zeinab,1399,A Few Steps Ahead to Select ACE۲ in Pediatric COVID-۱۹ Treatment: A Review of Literature,https://civilica.com/doc/1738708

Scientometrics

The specifications of the publisher center of this Paper are as follows:

Ranking of Zahedan University of Medical Science

Type of center: علوم پزشکی

Paper count: 2,089

In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.